Clinigen new.png
Clinigen launches NaviGATE: an educational programme for rare disease patients and organisations
September 12, 2023 07:00 ET | Clinigen
12 September 2023 Clinigen launches NaviGATE: an educational programme for rare diseasepatients and organisations             Accessing hard to reach medicines for people who need them most...
Clinigen new.png
Clinigen divests global rights to four cancer support therapies to CNX Therapeutics
August 10, 2023 09:46 ET | Clinigen
10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the...
Clinigen-Group-Plc-logo.jpg
Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million
January 23, 2023 08:07 ET | Clinigen
23 January 2023 Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million The deal includes a £41.7 million milestone payment and double-digit Proleukin® global sales royalties ...
Clinigen-Group-Plc-logo.jpg
Clinigen initiates a Managed Access Program for relugolix in Europe for the treatment of advanced hormone-sensitive prostate cancer
December 20, 2022 02:00 ET | Clinigen
20 December 2022 Clinigen initiates a Managed Access Program for relugolix in Europe for the treatment of advanced hormone-sensitive prostate cancer Clinigen Limited (‘Clinigen’), the global...
Clinigen-Group-Plc-logo.jpg
Clinigen notes results from the MIROCALS trial investigating low dose Proleukin® (aldesleukin) in patients with amyotrophic lateral sclerosis
December 08, 2022 04:12 ET | Clinigen
8 December 2022Clinigen notes results from the MIROCALS trial investigating low dose Proleukin® (aldesleukin) in patients with amyotrophic lateral sclerosisClinigen Limited (‘Clinigen’), the global...
Clinigen-Group-Plc-logo.jpg
Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator
November 29, 2022 02:00 ET | Clinigen
November 29, 2022 Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical services...
Clinigen-Group-Plc-logo.jpg
Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services
May 24, 2022 04:00 ET | Clinigen
24 May 2022 Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical...